Cyancobalamin

Manufacturer: Phoenix Meds, Inc.
Effective date: 2014-09-03
Label type: DIETARY SUPPLEMENT
Version: 3
Source: full-release
Hydrated at: 2026-06-01 02:47:59

Label at a glance#

ProductCyancobalamin

Active ingredientCYANOCOBALAMIN

Label structure1 sections

Label contents#

Full prescribing information#

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Cyanocobalamin_50mL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
309594	cyanocobalamin 1000 MCG/ML Injectable Solution	PSN	3
309594	vitamin B12 1 MG/ML Injectable Solution	SCD	3
309594	cyanocobalamin 1 MG/ML Injectable Solution	SY	3
309594	cyanocobalamin 1000 MCG/ML Injectable Solution	SY	3

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
CYANOCOBALAMIN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8	Product name	2	20240805
d206bb34-ea65-399d-70d9-834f22dc2c18	Product name	3	20170724

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
69029-110-02	Cyancobalamin	50 mL in 1 VIAL	INJECTION	50		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69029-110	CYANCOBALAMIN INJECTION [PHOENIX MEDS, INC.]	3	1 package rows	20140903_d8d9a067-438f-4095-8500-903f3e47f274.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CYANOCOBALAMIN	ACTIVE INGREDIENT	P6YC3EG204	3
CYANOCOBALAMIN	ACTIVE MOIETY	P6YC3EG204	3
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	3
SODIUM	INACTIVE INGREDIENT	9NEZ333N27	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

Cyancobalamin
CYANOCOBALAMIN
BENZYL ALCOHOL
SODIUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
69029-110	69029-110-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CYANOCOBALAMIN	P6YC3EG204	ACTIB
BENZYL ALCOHOL	LKG8494WBH	IACT
SODIUM	9NEZ333N27	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 50 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS		18 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SPRAY / NASAL		5 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRASYNOVIAL		18 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	GEL / TOPICAL		185 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	8.4 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRACAVITARY	0.01 ml		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / SUBCONJUNCTIVAL		252 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / INTRAMUSCULAR		54 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / SUBCUTANEOUS		225 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	GEL / VAGINAL		100 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SHAMPOO / TOPICAL	1.25 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRAMUSCULAR		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LIQUID / INTRAVENOUS	1.04 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CREAM / VAGINAL	1 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / INTRAVENOUS		242 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRAMUSCULAR		500 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / ORAL		100 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / RECTAL	129 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / ORAL		360 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTICULAR	1 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRAVENOUS		400 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / SOFT TISSUE		23 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	GEL / RECTAL		124 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / TOPICAL	1 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	144 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / ENDOTRACHEAL		54 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRA-ARTICULAR		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CAPSULE, EXTENDED RELEASE / ORAL	1.23 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET, DELAYED RELEASE / ORAL	2.31 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRALESIONAL		23 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / SUBCUTANEOUS	0.95 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LOTION / TOPICAL		4000 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAMUSCULAR		1000 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / INTRAMUSCULAR		225 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	144 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET / ORAL	1.06 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CAPSULE / ORAL		450 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / SUBCUTANEOUS		90 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTERIAL	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	OINTMENT / TOPICAL	2.2 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRALESIONAL		20 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / TOPICAL	2 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / SOFT TISSUE		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAVENOUS		1620 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SPRAY, METERED / NASAL	5 mg/1ml		Exact identifier — unii candidate 50 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CYANOCOBALAMIN	CYANOCOBALAMIN	HF Acquisition Co LLC, DBA HealthFirst	54f088b1-7cf8-3837-e063-6294a90a88e7	2026-09-02	Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Lifestar Pharma LLC	b1e35c97-2157-454e-967f-53a4300827de	2026-08-06	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	NorthStar RxLLC	ce0183b3-4410-466a-b57d-cd360d461b7c	2026-08-06	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Non-proprietary name	CYANOCOBALAMIN	Xseer Pharmaceuticals	3bb870d8-128d-75ea-e063-6394a90a707b	2026-05-13		Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Plano Pharmaceuticals Inc.	4cbc05f6-4b31-4a5f-e063-6394a90a676c	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
cyanocobalamin	CYANOCOBALAMIN	Sportpharm LLC	647842f4-b211-4f52-8b73-975fae767023	2026-02-05	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	A-S Medication Solutions	a61181f5-7e2d-45f9-929a-cb8bc70c992e	2026-01-06	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	SOLA Pharmaceuticals	e559c6c8-2973-77fb-e053-2995a90af43d	2025-12-08	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	BluePoint Laboratories	5c603ad0-9023-44cc-955c-3988d5dcf0d3	2025-12-05	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
CYANOCOBALAMIN	CYANOCOBALAMIN	Henry Schein, Inc.	ff32f34b-89b3-4617-ad42-2e8bcb88627e	2025-10-16	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Henry Schein, Inc.	92f08572-cfd9-4a99-bb49-937ab94eeb62	2025-09-10	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
cyanocobalamin	CYANOCOBALAMIN	Somerset Therapeutics, LLC	41ac0dc1-0a71-4c69-8e25-ba838f5f16a3	2025-09-04	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
CYANOCOBALAMIN	CYANOCOBALAMIN	Somerset Therapeutics, LLC	617e44f8-df80-4764-85b9-be0fb6da8db3	2025-08-29	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Meitheal Pharmaceuticals Inc.	064c6841-3ed2-417f-a77c-a730785b6036	2025-06-12	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
CYANOCOBALAMIN	CYANOCOBALAMIN	HF Acquisition Co LLC, DBA HealthFirst	9d4ac337-5f4d-ef47-e053-2a95a90a6dbf	2025-01-08	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Vitruvias Therapeutics	2117af8a-723f-4e2f-98a6-83ad2c423751	2024-12-20	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Fresenius Kabi USA, LLC	acff4ff3-4435-4995-a117-dbfcdf72334a	2024-12-15	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Fresenius Kabi USA, LLC	8b1cdee5-3368-40e4-90bf-31a64df1f38a	2024-12-12	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Meitheal Pharmaceuticals Inc.	9c37fd25-2143-410c-8d89-d39aa5c7b453	2024-11-22	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN
Cyanocobalamin	CYANOCOBALAMIN	Meitheal Pharmaceuticals Inc.	c6436212-9246-4e29-8540-9af992b667eb	2024-06-03	Warnings, Adverse reactions	Name fallback generic name: CYANOCOBALAMIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.